Clinical Trial Update: The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS) [Phase 4]

View source ↗

Summary

This clinical trial update reports on the efficacy of partially hydrolyzed guar gum (PHGG) for treating irritable bowel syndrome in a Phase 4 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• PHGG (Partially Hydrolyzed Guar Gum) (partially hydrolyzed guar gum)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: IBS | Phase 4 | Status: UNKNOWN